Search for Clinical Trial Results
Neovascularization, Pathologic - 25 Studies Found
Status | Study |
Completed |
Study Name: Bevacizumab Intravitreal for Myopic Choroidal Neovascularization Condition: Myopic Choroidal Neovascularization Date: 2008-11-24 Interventions: Drug: Injection Intravitreal injection of 1.25 mg bevacizumab |
Completed |
Study Name: Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. Condition: Choroidal Neovascularization (CNV) Date: 2013-04-23 Interventions:
|
Active, not recruiting |
Study Name: Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia Condition: Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia Date: 2012-10-25 Interventions: Drug: Bevazizumab intravitreal injection Intravitreal injection of bevacizumab |
Active, not recruiting |
Study Name: Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases Condition: Neovascularization, Pathologic Date: 2015-05-15 Interventions: Drug: ACM-1 intravitreal injection with 50ul ACM-1 at a concentration of 1600ug/ml |
Withdrawn |
Study Name: Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID). Condition: Choroidal Neovascularization in Angioid Streaks Date: 2015-10-07 Interventions: Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o |